Showing results (1511-1520 of 1,570) with videos related to
Sort By:
Pageof 157
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 9, 2018
[Efficacy and Influencing Factors of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Retrospective Analysis]Bing-Lei Zhang, Jian Zhou, Gong-Li Zhang, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2007
[Application of all-trans retinoic acid combining chemotherapy and As4S4 in the maintenance treatment of patients with acute promyelocytic leukemia]Quan-de Lin, Xu-dong Wei, Ping Wang, et al.Nature Communications|April 24, 2023
Integrated opposite charge grafting induced ionic-junction fiberYi Xing, Mingjie Zhou, Yueguang Si, et al.BMJ Open|August 29, 2022
Factors Associated with the Magnitude Of acUpuncture treatment effectS (FAMOUS): a meta-epidemiological study of acupuncture randomised controlled trialsWei-Juan Gang, Wen-Cui Xiu, Lan-Jun Shi, et al.Acta Pharmacologica Sinica|April 24, 2025
Celastrol inhibits the DPYSL2-JAK/STAT pathway by targeting mito-IDHs mediated mitochondrial metabolism to exhaust breast cancerQiao-Li Shi, Chen-Ran Feng, Hui-Ying Li, et al.Journal of Proteome Research|August 16, 2025
Podocyte Proteomics Revealed hUCMSC-Exosomes Ameliorate Diabetic Kidney Disease through Inhibiting Talin-1 Mediated EMTZhen Zhang, Cong-Min Tang, Wen-Zhuo Yu, et al.Nature Communications|July 25, 2017
High performance platinum single atom electrocatalyst for oxygen reduction reactionJing Liu, Menggai Jiao, Lanlu Lu, et al.Journal of Cellular and Molecular Medicine|January 24, 2020
Vitamin B6 inhibits macrophage activation to prevent lipopolysaccharide-induced acute pneumonia in miceMei-Rong Shan, Sheng-Nan Zhou, Chang-Ning Fu, et al.Nature Communications|September 28, 2017
Erratum: High performance platinum single atom electrocatalyst for oxygen reduction reactionJing Liu, Menggai Jiao, Lanlu Lu, et al.The Lancet. Oncology|June 10, 2018
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trialHong-Hu Zhu, De-Pei Wu, Xin Du, et al.Pageof 157